EPO Patents = 3

Trademarks = 2

Forward Citations = 59

Loading Chart...

4 inventors (with patents filed for the assignee):

Samuel Gavard Molliard (2 out of 2 patents)

Olivier Benoit (2 out of 3 patents)

Gilles Bos (2 out of 2 patents)

4. Philippe Sourdille (1 out of 3 patents)

4 patents: Sort by Forward Citations

1. 10028976 - Injectable formulation of natural polysaccharide and polyol for treatment of osteoarthritis (2018-07-24),

2. 9339514 - Method for treating glaucoma (2016-05-17),

3. 9138405 - Use of a natural polysaccharide gel for the preparation of an injectable formulation for treatment of articular degeneration (2015-09-22),

4. 8715266 - Glaucoma surgery (2014-05-06),

Aptissen Sa is a Swiss biotechnology company specializing in the development and commercialization of innovative solutions for tissue repair and regeneration. With a focus on orthopedics and wound care, Aptissen Sa strives to provide cutting-edge products that improve patient outcomes and quality of life. Through research and collaboration with healthcare professionals, Aptissen Sa aims to advance the field of regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

4 Patents

#13 in Plan-les-Ouates

#2,111 in Switzerland

Plan-les-Ouates, Switzerland

Aptissen Sa

Forward Citations = 59

4 inventors:

Samuel Gavard Molliard (2 out of 2 patents)

Olivier Benoit (2 out of 3 patents)

Gilles Bos (2 out of 2 patents)

4. Philippe Sourdille (1 out of 3 patents)

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com